Intracerebroventricular gene therapy that delays neurological disease progression is associated with selective preservation of retinal ganglion cells in a canine model of CLN2 disease.
about
Extraneuronal pathology in a canine model of CLN2 neuronal ceroid lipofuscinosis after intracerebroventricular gene therapy that delays neurological disease progression.CLINICAL PROGRESS IN INHERITED RETINAL DEGENERATIONS: GENE THERAPY CLINICAL TRIALS AND ADVANCES IN GENETIC SEQUENCING.A canine model for neuronal ceroid lipofuscinosis highlights the promise of gene therapy for lysosomal storage diseases.Canine neuronal ceroid lipofuscinoses: Promising models for preclinical testing of therapeutic interventions.
P2860
Intracerebroventricular gene therapy that delays neurological disease progression is associated with selective preservation of retinal ganglion cells in a canine model of CLN2 disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 March 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Intracerebroventricular gene t ...... canine model of CLN2 disease.
@en
Intracerebroventricular gene t ...... canine model of CLN2 disease.
@nl
type
label
Intracerebroventricular gene t ...... canine model of CLN2 disease.
@en
Intracerebroventricular gene t ...... canine model of CLN2 disease.
@nl
prefLabel
Intracerebroventricular gene t ...... canine model of CLN2 disease.
@en
Intracerebroventricular gene t ...... canine model of CLN2 disease.
@nl
P2093
P2860
P1476
Intracerebroventricular gene t ...... canine model of CLN2 disease.
@en
P2093
Cheryl A Jensen
Daniel E Bristow
Jacqueline W Pearce
Lauren E Gillespie
Martin L Katz
Rebecca E H Whiting
P2860
P304
P356
10.1016/J.EXER.2016.03.023
P577
2016-03-31T00:00:00Z